CAROLINE METZEL DIAZ: Open Payments
NPI 1972931723 · AVENTURA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,881 in 141 payments from 30 companies in 2025. Trend: 2023 $971 · 2024 $2,258 · 2025 $2,881
Food & beverage: $2,582Long term medical supply or device loan: $299
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $404 |
| Daiichi Sankyo Inc. | 13 | $317 |
| TerSera Therapeutics LLC | 11 | $262 |
| AstraZeneca Pharmaceuticals LP | 10 | $255 |
| GlaxoSmithKline, LLC. | 11 | $188 |
| PFIZER INC. | 8 | $171 |
| SERVIER PHARMACEUTICALS LLC | 6 | $164 |
| Eisai Inc. | 17 | $150 |
| Merck Sharp & Dohme LLC | 9 | $135 |
| JAZZ PHARMACEUTICALS INC. | 6 | $111 |
Products named: KISQALI, Enhertu, Zoladex, JEMPERLI, Lenvima, DATROWAY, ZIIHERA, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
